{"CONCEPT_ID":[1786621],"CDM_TABLE_NAME":["DRUG_ERA"],"CONCEPT_NAME":["cephalexin"],"NUM_PERSONS":[9],"PERCENT_PERSONS":["0.0826"],"RECORDS_PER_PERSON":["1.0"],"AGE_AT_FIRST_EXPOSURE":[{"CATEGORY":"FEMALE","MIN_VALUE":15,"P10_VALUE":15,"P25_VALUE":16,"MEDIAN_VALUE":17,"P75_VALUE":22,"P90_VALUE":45,"MAX_VALUE":45}],"PREVALENCE_BY_GENDER_AGE_YEAR":[{"TRELLIS_NAME":"10-19","SERIES_NAME":"FEMALE","X_CALENDAR_YEAR":1974,"Y_PREVALENCE_1000PP":166.6667},{"TRELLIS_NAME":"10-19","SERIES_NAME":"FEMALE","X_CALENDAR_YEAR":2008,"Y_PREVALENCE_1000PP":153.8461},{"TRELLIS_NAME":"20-29","SERIES_NAME":"FEMALE","X_CALENDAR_YEAR":2013,"Y_PREVALENCE_1000PP":71.4286},{"TRELLIS_NAME":"10-19","SERIES_NAME":"FEMALE","X_CALENDAR_YEAR":2023,"Y_PREVALENCE_1000PP":125}],"PREVALENCE_BY_MONTH":[{"X_CALENDAR_MONTH":200909,"Y_PREVALENCE_1000PP":11.4942},{"X_CALENDAR_MONTH":202304,"Y_PREVALENCE_1000PP":10.4167},{"X_CALENDAR_MONTH":202209,"Y_PREVALENCE_1000PP":10.4167},{"X_CALENDAR_MONTH":201306,"Y_PREVALENCE_1000PP":11.1111},{"X_CALENDAR_MONTH":200802,"Y_PREVALENCE_1000PP":11.7647},{"X_CALENDAR_MONTH":200811,"Y_PREVALENCE_1000PP":11.4942},{"X_CALENDAR_MONTH":201904,"Y_PREVALENCE_1000PP":10.7527},{"X_CALENDAR_MONTH":201611,"Y_PREVALENCE_1000PP":10.989},{"X_CALENDAR_MONTH":197411,"Y_PREVALENCE_1000PP":50}],"LENGTH_OF_ERA":[{"CATEGORY":"Length of Era","MIN_VALUE":0,"P10_VALUE":0,"P25_VALUE":1,"MEDIAN_VALUE":1,"P75_VALUE":1,"P90_VALUE":2,"MAX_VALUE":2}]}
